Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01195116Phase 4Completed
Phase 4, randomised, double-blind trial of dexmedetomidine in interstitial cystitis (IC) (2 arms), sponsored by University of Rochester. Primary endpoint: Change in Pain Score (Visual Analogue Scale). Started May 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01195116.